Terms: = Lung cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Treatment
150 results:
1. Role of CD38 in anti-tumor immunity of small cell lung cancer.
Taniguchi H; Chavan SS; Chow A; Chan JM; Mukae H; Rudin CM; Sen T
Front Immunol; 2024; 15():1348982. PubMed ID: 38533509
[TBL] [Abstract] [Full Text] [Related]
2. Mediator complex subunit 1 architects a tumorigenic Treg cell program independent of inflammation.
Chaudhuri SM; Weinberg SE; Wang D; Yalom LK; Montauti E; Iyer R; Tang AY; Torres Acosta MA; Shen J; Mani NL; Wang S; Liu K; Lu W; Bui TM; Manzanares LD; Dehghani Z; Wai CM; Gao B; Wei J; Yue F; Cui W; Singer BD; Sumagin R; Zhang Y; Fang D
Cell Rep Med; 2024 Mar; 5(3):101441. PubMed ID: 38428427
[TBL] [Abstract] [Full Text] [Related]
3. Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer.
Shibaki R; Fujimoto D; Nozawa T; Sano A; Kitamura Y; Fukuoka J; Sato Y; Kijima T; Matsumoto H; Yokoyama T; Miura S; Hata A; Tamiya M; Taniguchi Y; Sugisaka J; Furuya N; Tanaka H; Yamamoto N; Koh Y; Akamatsu H
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38360040
[TBL] [Abstract] [Full Text] [Related]
4. Tumor microenvironment(TME) and single-source dual-energy CT(ssDECT) on assessment of inconformity between RECIST1.1 and pathological remission in neoadjuvant immunotherapy of NSCLC.
Sun C; Ma X; Meng F; Chen X; Wang X; Sun W; Xu Y; He H; Zhang H; Ma K
Neoplasia; 2024 Apr; 50():100977. PubMed ID: 38354688
[TBL] [Abstract] [Full Text] [Related]
5. Association of Baseline Tumor-Specific Neoantigens and CD8
Kerepesi C; Abushukair HM; Ricciuti B; Nassar AH; Adib E; Alessi JV; Pecci F; Rakaee M; Fadlullah MZH; Tőkés AM; Rodig SJ; Awad MM; Tan AC; Bakacs T; Naqash AR
JCO Precis Oncol; 2024 Feb; 8():e2300439. PubMed ID: 38330262
[TBL] [Abstract] [Full Text] [Related]
6. Amplifying T cell-mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti-PD1.
Gong B; Wang L; Zhang H; Wang Q; Li W
Cell Biochem Funct; 2024 Jan; 42(1):e3925. PubMed ID: 38269509
[TBL] [Abstract] [Full Text] [Related]
7. Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.
Mouri A; Kaira K; Yamaguchi O; Hashimoto K; Miura Y; Shiono A; Kawasaki T; Kobayashi K; Imai H; Kagamu H
Int J Clin Oncol; 2024 Feb; 29(2):124-133. PubMed ID: 38160406
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells.
Zhang K; Sun T; Li W; Guo Y; Li A; Hsieh M; Wang J; Wu J; Arvanitis L; Raz DJ
Cell Commun Signal; 2023 Nov; 21(1):319. PubMed ID: 37946202
[TBL] [Abstract] [Full Text] [Related]
9. Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.
Alessi JV; Price A; Richards AL; Ricciuti B; Wang X; Elkrief A; Pecci F; Di Federico A; Gandhi MM; Lebow ES; Santos PMG; Thor M; Rimner A; Schoenfeld AJ; Chaft JE; Johnson BE; Gomez DR; Awad MM; Shaverdian N
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37914383
[TBL] [Abstract] [Full Text] [Related]
10. Targeting foxp3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast cancer.
Nicola Candia AJ; Garcia Fallit M; Peña Agudelo JA; Pérez Küper M; Gonzalez N; Moreno Ayala MA; De Simone E; Giampaoli C; Casares N; Seilicovich A; Lasarte JJ; Zanetti FA; Candolfi M
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766222
[TBL] [Abstract] [Full Text] [Related]
11. lung tumor-infiltrating T
Dykema AG; Zhang J; Cheung LS; Connor S; Zhang B; Zeng Z; Cherry CM; Li T; Caushi JX; Nishimoto M; Munoz AJ; Ji Z; Hou W; Zhan W; Singh D; Zhang T; Rashid R; Mitchell-Flack M; Bom S; Tam A; Ionta N; Aye THK; Wang Y; Sawosik CA; Tirado LE; Tomasovic LM; VanDyke D; Spangler JB; Anagnostou V; Yang S; Spicer J; Rayes R; Taube J; Brahmer JR; Forde PM; Yegnasubramanian S; Ji H; Pardoll DM; Smith KN
Sci Immunol; 2023 Sep; 8(87):eadg1487. PubMed ID: 37713507
[TBL] [Abstract] [Full Text] [Related]
12. A novel telomere-related gene prognostic signature for survival and drug treatment efficiency prediction in lung adenocarcinoma.
Chen H; Liang W; Zheng W; Li F; Pan X; Lu Y
Aging (Albany NY); 2023 Aug; 15(16):7956-7973. PubMed ID: 37589509
[TBL] [Abstract] [Full Text] [Related]
13. Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell lung cancer.
Chen T; Cao Z; Sun Y; Huang J; Shen S; Jin Y; Jiang L; Wen F; Zhao X; Zhang D; Chen Y; Huang M; Chen H; Lu S; Li Z
Ann Surg Oncol; 2023 Nov; 30(12):7549-7560. PubMed ID: 37587362
[TBL] [Abstract] [Full Text] [Related]
14. Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI treatment in ALK-Rearranged Non-Small Cell lung cancer.
Zheng N; Zhang Y; Zeng Y; Ma Q; Zhang R; Zhao Q; Lu C; Tian J; Wang Z; Tang H; Luo N; Xiao H; He Y; Wu F; Li L
Target Oncol; 2023 Jul; 18(4):625-636. PubMed ID: 37351800
[TBL] [Abstract] [Full Text] [Related]
15. Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
Rodrigues M; Vanoni G; Loap P; Dubot C; Timperi E; Minsat M; Bazire L; Durdux C; Fourchotte V; Laas E; Pouget N; Castel-Ajgal Z; Marret G; Lesage L; Meseure D; Vincent-Salomon A; Lecompte L; Servant N; Vacher S; Bieche I; Malhaire C; Huchet V; Champion L; Kamal M; Amigorena S; Lantz O; Chevrier M; Romano E
Nat Commun; 2023 Jun; 14(1):3698. PubMed ID: 37349318
[TBL] [Abstract] [Full Text] [Related]
16. IL-33's role in the gut immune system: A comprehensive review of its crosstalk and regulation.
Kaur H; Kaur G; Ali SA
Life Sci; 2023 Aug; 327():121868. PubMed ID: 37330043
[TBL] [Abstract] [Full Text] [Related]
17. Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.
Rocha P; Rodrigo M; Moliner L; Menendez S; Masfarré L; Navarro N; Del Rey-Vergara R; Galindo-Campos M; Taus Á; Giner M; Sanchez I; Rodríguez-Fuster A; Aguiló R; Chalela R; Sánchez-Font A; Belda J; Curull V; Pijuan L; Casadevall D; Clavé S; Bellosillo B; Perera-Bel J; Comerma L; Arriola E
Lung Cancer; 2023 Jul; 181():107257. PubMed ID: 37263182
[TBL] [Abstract] [Full Text] [Related]
18. High density and proximity of CD8
Yin Y; Sakakibara R; Honda T; Kirimura S; Daroonpan P; Kobayashi M; Ando K; Ujiie H; Kato T; Kaga K; Mitsumura T; Nakano R; Sakashita H; Matsuge S; Ishibashi H; Akashi T; Hida Y; Morohoshi T; Azuma M; Okubo K; Miyazaki Y
Thorac Cancer; 2023 Jul; 14(20):1991-2000. PubMed ID: 37253418
[TBL] [Abstract] [Full Text] [Related]
19. Multi-omic and spatial dissection of immunotherapy response groups in non-small cell lung cancer.
Monkman J; Kim H; Mayer A; Mehdi A; Matigian N; Cumberbatch M; Bhagat M; Ladwa R; Mueller SN; Adams MN; O'Byrne K; Kulasinghe A
Immunology; 2023 Aug; 169(4):487-502. PubMed ID: 37022147
[TBL] [Abstract] [Full Text] [Related]
20. Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non-small-cell lung cancer.
Han R; Zhang Y; Wang T; Xiao H; Luo Z; Shen C; Li J; Zhao C; Li L; Zhu M; Du H; Tang H; Ma Z; Wang Y; He Y
Cancer Sci; 2023 Jun; 114(6):2569-2583. PubMed ID: 36880750
[TBL] [Abstract] [Full Text] [Related]
[Next]
